| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $181.55K | $319.94K | $230.06K | $242.88K | $1.77M |
| Operating Income | -$281.55K | -$742.50K | -$1.42M | -$1.28M | -$1.77M |
| Interest Expense | – | – | $101.42K | $282.33K | $230.65K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$432.02K | -$769.81K | -$1.46M | -$1.56M | -$2.06M |
| EPS (basic) | -0.0200 | -0.0300 | -0.0800 | -0.1300 | -0.2300 |
| EPS (diluted) | -0.0200 | -0.0300 | -0.0800 | -0.1300 | -0.2300 |
| Shares (diluted) | $27.08M | $25.52M | $19.22M | $11.74M | $9.48M |